NASH Screening
NASH Screening in Diabetes

Released: July 07, 2020

Expiration: July 06, 2021

Activity

Progress
1
Course Completed

Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk, including:

  • Should We Screen for NASH?
    • Role of obesity and type 2 diabetes mellitus
  • Cardiovascular Risk in NAFLD/NASH
  • How to Evaluate for NAFLD/NASH
    • Biomarkers
    • Imaging
    • When/whom to biopsy?
  • Management in Multidisciplinary Settings

Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/screening-for-nash-in-patients-with-diabetes/slideset

See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics